Auro Laboratories EBITDA per Share

What does Auro Laboratories do? Auro Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India. The company engages in the manufacture of active pharmaceutical ingredients (APIs), intermediates, and generic formulations. It operates primarily within the Pharmaceuticals sector. Auro Laboratories offers APIs across various therapeutic categories, including antihistamines, muscle relaxants, diuretics, iron deficiency treatments, anti-diabetics, anti-fungals, anti-ulcer medications, iodine supplements, anti-malarials, analgesics, antacids, and anti-inflammatories. The company also produces intermediates such as Glibenclamide Sulphonamide, Cis-bromo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid, 3,4,5-Trimethoxy Benzoic Acid, and 5-Bromo Phthalide. Additionally, Auro Laboratories provides toll and custom manufacturing services for APIs and intermediates on a contract basis. The company has an international presence, with a significant portion of its production exported to Southeast Asia, the Middle East, and various European countries. Key export destinations include Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. Auro Laboratories went public with its IPO on March 7, 1995. The company's website is http://www.aurolabs.com/. Auro Laboratories is one of the most popular companies on Eulerpool.